Browse > Article
http://dx.doi.org/10.1016/j.jgr.2015.07.006

Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease  

Hong, Meegun (Department of Internal Medicine, Hallym University College of Medicine)
Lee, Yoon Hyeong (Department of Internal Medicine, Hallym University College of Medicine)
Kim, Seungwoo (Department of Biomedical Science, Hallym University College of Medicine)
Suk, Ki Tae (Department of Internal Medicine, Hallym University College of Medicine)
Bang, Chang Seok (Department of Internal Medicine, Hallym University College of Medicine)
Yoon, Jai Hoon (Department of Internal Medicine, Hallym University College of Medicine)
Baik, Gwang Ho (Department of Internal Medicine, Hallym University College of Medicine)
Kim, Dong Joon (Department of Internal Medicine, Hallym University College of Medicine)
Kim, Myong Jo (College of Agriculture and Life Science, Kangwon National University)
Publication Information
Journal of Ginseng Research / v.40, no.3, 2016 , pp. 203-210 More about this Journal
Abstract
Background: Korean Red Ginseng (KRG) is a well-known natural product with anticarcinogenic and antioxidant effects. We evaluated the antifatigue effect of KRG in patients with nonalcoholic fatty liver disease (NAFLD). Methods: Eighty patients with NAFLD were prospectively randomized to receive 3 wk of KRG or placebo in addition to counseling on healthy eating and regular exercise. Liver function test, proinflammatory cytokines, adiponectin, antioxidant activity, and fatigue score were measured and compared according to the body mass index between the KRG and placebo groups. Results: The liver function tests were significantly improved after 3 wk of treatment in both groups. The mean levels (at baseline and after treatment) of tumor necrosis factor-${\alpha}$ were $108.0pg/mL{\pm}54.8pg/mL$ and $92.7pg/mL{\pm}39.0pg/mL$ (p = 0.018) in the KRG group and $123.1pg/mL{\pm}42.1pg/mL$ and $127.5pg/mL{\pm}62.2pg/mL$ (p = 0.694) in the placebo group, respectively. There was a significant difference in change of adiponectin levels between the KRG ($7,751.2pg/mL{\pm}3,108.1pg/mL$ and $8,197.3pg/mL{\pm}2,714.5pg/mL$) and placebo groups ($7,711.6pg/mL{\pm}3,041.3pg/mL$ and $7,286.1pg/mL{\pm}5,188.7pg/mL$, p = 0.027). In patients with overweight, the fatigue score was significantly decreased in the KRG group ($35.0{\pm}13.2$ and $24.5{\pm}8.9$, p = 0.019). Conclusion: Our results show that KRG might be effective in reducing proinflammatory cytokine and fatigue in overweight patients with NAFLD, in addition to improvements in adiponectin levels.
Keywords
adiponectin; chronic hepatitis; fatty liver; Panax ginseng;
Citations & Related Records
Times Cited By KSCI : 5  (Citation Analysis)
연도 인용수 순위
1 Brunt EM. Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. Dig Dis 2012;30:61-8.   DOI
2 Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313-21.   DOI
3 Review Team, LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, et al. World Gastroenterology Organisation global guidelines: nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 2014;48:467-73.
4 Newton JL, Jones DE, Henderson E, Kane L, Wilton K, Burt AD, Day CP. Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance. Gut 2008;57:807-13.   DOI
5 Morris G, Berk M, Walder K, Maes M. Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses. BMC Med 2015;13:28.   DOI
6 Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23.   DOI
7 Scalera A, Tarantino G. Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? World J Gastroenterol 2014;20:9217-28.
8 Jarosz PA, Davis JE, Yarandi HN, Farkas R, Feingold E, Shippings SH, Smith AL, Williams D. Obesity in urban women: associations with sleep and sleepiness, fatigue and activity. Womens Health Issues 2014;24:e447-54.   DOI
9 Hong SH, Suk KT, Choi SH, Lee JW, Sung HT, Kim CH, Kim EJ, Kim MJ, Han SH, Kim MY, et al. Anti-oxidant and natural killer cell activity of Korean Red Ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on nonalcoholic fatty liver disease of rat. Food Chem Toxicol 2013;55:586-91.   DOI
10 Bang CS, Hong SH, Suk KT, Kim JB, Han SH, Sung H, Kim EJ, Kim MJ, Kim MY, Baik SK, et al. Effects of Korean Red Ginseng (Panax ginseng), urushiol (Rhus vernicifera Stokes), and probiotics (Lactobacillus rhamnosus R0011 and Lactobacillus acidophilus R0052) on the gut-liver axis of alcoholic liver disease. J Ginseng Res 2014;38:167-72.   DOI
11 Choi JY, Woo TS, Yoon SY, Ike Campomayor Dela P, Choi YJ, Ahn HS, Lee YS, Yu GY, Cheong JH. Red ginseng supplementation more effectively alleviates psychological than physical fatigue. J Ginseng Res 2011;35:331-8.   DOI
12 Shen L, Xiong Y, Wang DQ, Howles P, Basford JE, Wang J, Xiong YQ, Hui DY, Woods SC, Liu M. Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res 2013;54:1430-8.   DOI
13 Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, et al. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst 2013;105:1230-8.   DOI
14 Ginseng helps cancer-related fatigue. Mayo Clin Health Lett 2012;30:4.
15 Katz P, Margaretten M, Trupin L, Schmajuk G, Yazdany J, Yelin E. Sleep disturbance, depression, obesity, and physical inactivity explain a significant portion of fatigue in rheumatoid arthritis. Arthritis Care Res 2016;68:81-90.   DOI
16 Brainina KhZ, Ivanova AV, Sharafutdinova EN, Lozovskaya EL, Shkarina EI. Potentiometry as a method of antioxidant activity investigation. Talanta 2007;71:13-8.   DOI
17 Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.   DOI
18 Kim HG, Cho JH, Yoo SR, Lee JS, Han JM, Lee NH, Ahn YC, Son CG. Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebocontrolled trial. PloS One 2013;8:e61271.   DOI
19 Promrat K, Kleiner DE, Niemeier HM, Jackvony E, Kearns M, Wands JR, Fava JL, Wing RR. Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 2010;51:121-9.   DOI
20 Jin YJ, Kim KM, Hwang S, Lee SG, Ha TY, Song GW, Jung DH, Kim KH, Yu E, Shim JH, et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol 2012;27:1341-7.   DOI
21 Ball KR, Kowdley KV. A review of Silybum marianum (milk thistle) as a treatment for alcoholic liver disease. J Clin Gastroenterol 2005;39:520-8.   DOI
22 Shaker E, Mahmoud H, Mnaa S. Silymarin, the antioxidant component and Silybum marianum extracts prevent liver damage. Food Chem Toxicol 2010;48:803-6.   DOI
23 Niranjana Murthy H, Dandin VS, Yoeup Paek K. Hepatoprotective activity of ginsenosides from Panax ginseng adventitious roots against carbon tetrachloride treated hepatic injury in rats. J Ethnopharmacol 2014;158:442-6.   DOI
24 Zhang SS, Wu ZY, Chen JM, Guo QK, Li L, Wang ZF, Gao Y, Ma ZC. Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet. Zhongguo Zhong Xi Yi Jie He Za Zhi 2014;34:56-61.
25 Seo SJ, Cho JY, Jeong YH, Choi YS. Effect of Korean Red Ginseng extract on liver damage induced by short-term and long-term ethanol treatment in rats. J Ginseng Res 2013;37:194-200.   DOI
26 Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 2005;6:13-21.   DOI
27 Zhao J, Shi Z, Liu S, Li J, Huang W. Ginsenosides Rg1 from Panax ginseng: a potential therapy for acute liver failure patients? Evid Based Complement Alternat Med 2014;2014:538059.
28 Yeo CR, Yang C, Wong TY, Popovich DG. A quantified ginseng (Panax ginseng C.A. Meyer) extract influences lipid acquisition and increases adiponectin expression in 3T3-L1 cells. Molecules 2011;16:477-92.   DOI
29 Song YB, An YR, Kim SJ, Park HW, Jung JW, Kyung JS, Hwang SY, Kim YS. Lipid metabolic effect of Korean Red Ginseng extract in mice fed on a high-fat diet. J Sci Food Agric 2012;92:388-96.   DOI
30 Quan HY, Kim do Y, Chung SH. Korean Red Ginseng extract alleviates advanced glycation end product-mediated renal injury. J Ginseng Res 2013;37:187-93.   DOI
31 Cho YJ, Son HJ, Kim KS. A 14-week randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy and safety of ginseng polysaccharide (Y-75). J Transl Med 2014;12:283.   DOI
32 Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-9.   DOI
33 Fan JS, Liu DN, Huang G, Xu ZZ, Jia Y, Zhang HG, Li XH, He FT. Panax notoginseng saponins attenuate atherosclerosis via reciprocal regulation of lipid metabolism and inflammation by inducing liver X receptor alpha expression. J Ethnopharmacol 2012;142:732-8.   DOI
34 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines: management of nonalcoholic fatty liver disease. Clin Mol Hepatol 2013;19:325-48.   DOI